Replies to post #101515 on Biotech Values

[DewDiligence]

I don't see Takeda's TAK-442 on the list.

From now on, I’ll include it :- ) Have the results of the TAK-442 phase-2 study in ACS been reported yet?

[genisi]

One more for that list is Astellas YM-150:
Source: http://www.astellas.com/en/ir/library/pdf/1q2011_pre_en.pdf

[DewDiligence]

Clinical trials for Takeda’s oral FXa inhibitor, TAK-442

Phase-2 in ACS:
http://clinicaltrials.gov/ct2/show/NCT00677053

Phase-2 in VTE prevention following knee surgery:
http://clinicaltrials.gov/ct2/show/NCT00641732

[DewDiligence]

Takeda’s TAK-442 has evidently been discontinued; the most recent study listed in clinicaltrials.gov ended more than two years ago (http://www.clinicaltrials.gov/ct2/results?term=%22tak-442%22 ).